ArticleFrontiers in oncologyPublished
Time and cost burden associated with docetaxel in patients with metastatic castration-sensitive prostate cancer initiating an androgen receptor pathway inhibitor-based regimen
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Frontiers in oncology
- Published
- Topic
- Clinical care
- Subject terms
- Prostate neoplasms; Chemotherapy; Androgen Receptor Antagonists; Triplet Therapy; Time Burden; Mcspc; Hormone Receptor Agonists
- PubMed ID
- 41079090
- PubMed Central ID
- PMC12512215
- Open access
- Yes, open
- Added to directory
- Source checked